IL124354A0 - Hemoregulatory compounds - Google Patents

Hemoregulatory compounds

Info

Publication number
IL124354A0
IL124354A0 IL12435496A IL12435496A IL124354A0 IL 124354 A0 IL124354 A0 IL 124354A0 IL 12435496 A IL12435496 A IL 12435496A IL 12435496 A IL12435496 A IL 12435496A IL 124354 A0 IL124354 A0 IL 124354A0
Authority
IL
Israel
Prior art keywords
hemoregulatory
compounds
hemoregulatory compounds
fungal
viral
Prior art date
Application number
IL12435496A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp And Ny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp And Ny filed Critical Smithkline Beecham Corp And Ny
Publication of IL124354A0 publication Critical patent/IL124354A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Amplifiers (AREA)
  • Microwave Amplifiers (AREA)
  • Junction Field-Effect Transistors (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL12435496A 1995-11-13 1996-11-12 Hemoregulatory compounds IL124354A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US657195P 1995-11-13 1995-11-13
US657395P 1995-11-13 1995-11-13
PCT/US1996/018126 WO1997017964A1 (fr) 1995-11-13 1996-11-12 Composes hemoregulateurs

Publications (1)

Publication Number Publication Date
IL124354A0 true IL124354A0 (en) 1998-12-06

Family

ID=26675804

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12435496A IL124354A0 (en) 1995-11-13 1996-11-12 Hemoregulatory compounds

Country Status (15)

Country Link
EP (1) EP0861077B1 (fr)
JP (1) JP2000500751A (fr)
KR (1) KR19990067506A (fr)
CN (1) CN1209061A (fr)
AT (1) ATE212839T1 (fr)
AU (1) AU711239B2 (fr)
BR (1) BR9611520A (fr)
CZ (1) CZ147098A3 (fr)
DE (1) DE69619123D1 (fr)
IL (1) IL124354A0 (fr)
NO (1) NO310656B1 (fr)
NZ (1) NZ323207A (fr)
PL (1) PL326631A1 (fr)
TR (1) TR199800850T2 (fr)
WO (1) WO1997017964A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114357A (en) * 1995-11-13 2000-09-05 Smithkline Beecham Corporation Hemoregulatory compounds
DE69915434T2 (de) * 1998-12-07 2005-03-03 Dsm Ip Assets B.V. Verfahren und Vorrichtung zum Mischen oder Dispergieren von Flüssigkeiten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917626A (en) * 1971-03-29 1975-11-04 Ici Ltd 3,6-Dioxa-1,8-octandiamido bis (pyridinium) compounds
FI77875C (fi) * 1982-11-26 1989-05-10 Nyegaard & Co As Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptider.
US4544661A (en) * 1983-09-23 1985-10-01 Chevron Research Company Fungicidal N-pyridyloxy alkyl amines
JPH0381222A (ja) * 1989-08-22 1991-04-05 Yoshitomi Pharmaceut Ind Ltd 制癌剤
JP2994182B2 (ja) * 1992-07-23 1999-12-27 石原産業株式会社 アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
US5830867A (en) * 1993-05-24 1998-11-03 Smithkline Beecham Corporation Hemoregulatory peptides for stimulating the myelopoietic system

Also Published As

Publication number Publication date
KR19990067506A (ko) 1999-08-25
WO1997017964A1 (fr) 1997-05-22
EP0861077B1 (fr) 2002-02-06
NZ323207A (en) 1999-11-29
NO982151D0 (no) 1998-05-12
PL326631A1 (en) 1998-10-12
EP0861077A1 (fr) 1998-09-02
EP0861077A4 (fr) 1999-03-03
CN1209061A (zh) 1999-02-24
CZ147098A3 (cs) 1999-02-17
JP2000500751A (ja) 2000-01-25
DE69619123D1 (de) 2002-03-21
BR9611520A (pt) 1999-12-28
NO310656B1 (no) 2001-08-06
ATE212839T1 (de) 2002-02-15
TR199800850T2 (xx) 1998-09-21
AU7728296A (en) 1997-06-05
AU711239B2 (en) 1999-10-07
NO982151L (no) 1998-07-03

Similar Documents

Publication Publication Date Title
ZA954679B (en) Bicyclic compounds
HU9602114D0 (en) Chloropyrimide intermediates
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
ZA951974B (en) Bradykinin antagonist peptides incorporating N-subsituted glycines
GB9425730D0 (en) Compounds
EP0621788A4 (en) Hemoregulatory peptides.
IL124354A0 (en) Hemoregulatory compounds
AU6722498A (en) Disubstituted biphenyloxazolines
BR9611904A (pt) Dioxidos de ditiazol
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
MD218C2 (ro) Stimulant pentru creşterea părului